USE OF A COMBINATION OF AN INHIBITOR OF THE IF CURRENT OF THE SINUS NODE AND AN INHIBITOR OF THE ANGIOTENSIN CONVERTING ENZYME FOR THE TREATMENT OF HEART FAILURE

摘要

Use of the combination of a selective and specific sinus Ip inhibitor, more particularly ivabradine or N - {[(7S) -3,4-dimethoxybicyclo [4.2.0] octa-1,3,5 tri-7-yl] methyl} -3- (7,8-dimethoxy-1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl) -N-methyl-3-oxo-1- propanamine and an angiotensin converting enzyme inhibitory agent for the production of medicaments for the treatment of heart failure, particularly heart failure with conservative systolic function. Drugs.